Literature DB >> 24563506

True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.

Edward S Mocarski1, William J Kaiser, Devon Livingston-Rosanoff, Jason W Upton, Lisa P Daley-Bauer.   

Abstract

Programmed necrosis mediated by receptor interacting protein kinase (RIP)3 (also called RIPK3) has emerged as an alternate death pathway triggered by TNF family death receptors, pathogen sensors, IFNRs, Ag-specific TCR activation, and genotoxic stress. Necrosis leads to cell leakage and acts as a "trap door," eliminating cells that cannot die by apoptosis because of the elaboration of pathogen-encoded caspase inhibitors. Necrotic signaling requires RIP3 binding to one of three partners-RIP1, DAI, or TRIF-via a common RIP homotypic interaction motif. Once activated, RIP3 kinase targets the pseudokinase mixed lineage kinase domain-like to drive cell lysis. Although necrotic and apoptotic death can enhance T cell cross-priming during infection, mice that lack these extrinsic programmed cell death pathways are able to produce Ag-specific T cells and control viral infection. The entwined relationship of apoptosis and necrosis evolved in response to pathogen-encoded suppressors to support host defense and contribute to inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24563506      PMCID: PMC3934821          DOI: 10.4049/jimmunol.1302426

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  121 in total

Review 1.  Immune evasion by adenoviruses.

Authors:  J A Mahr; L R Gooding
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Viral vectors as vaccine platforms: deployment in sight.

Authors:  Christine S Rollier; Arturo Reyes-Sandoval; Matthew G Cottingham; Katie Ewer; Adrian V S Hill
Journal:  Curr Opin Immunol       Date:  2011-04-20       Impact factor: 7.486

4.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

5.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.

Authors:  Jie Zhao; Siriporn Jitkaew; Zhenyu Cai; Swati Choksi; Qiuning Li; Ji Luo; Zheng-Gang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

6.  IAPs limit activation of RIP kinases by TNF receptor 1 during development.

Authors:  Maryline Moulin; Holly Anderton; Anne K Voss; Tim Thomas; Wendy Wei-Lynn Wong; Aleksandra Bankovacki; Rebecca Feltham; Diep Chau; Wendy D Cook; John Silke; David L Vaux
Journal:  EMBO J       Date:  2012-02-10       Impact factor: 11.598

Review 7.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

8.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Functional complementation between FADD and RIP1 in embryos and lymphocytes.

Authors:  Haibing Zhang; Xiaohui Zhou; Thomas McQuade; Jinghe Li; Francis Ka-Ming Chan; Jianke Zhang
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

View more
  43 in total

1.  CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3.

Authors:  Jinho Seo; Eun-Woo Lee; Hyerim Sung; Daehyeon Seong; Yves Dondelinger; Jihye Shin; Manhyung Jeong; Hae-Kyung Lee; Jung-Hoon Kim; Su Yeon Han; Cheolju Lee; Je Kyung Seong; Peter Vandenabeele; Jaewhan Song
Journal:  Nat Cell Biol       Date:  2016-02-22       Impact factor: 28.824

2.  Viral RNA at Two Stages of Reovirus Infection Is Required for the Induction of Necroptosis.

Authors:  Angela K Berger; Bradley E Hiller; Deepti Thete; Anthony J Snyder; Encarnacion Perez; Jason W Upton; Pranav Danthi
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

3.  Remarkably Robust Antiviral Immune Response despite Combined Deficiency in Caspase-8 and RIPK3.

Authors:  Yanjun Feng; Devon Livingston-Rosanoff; Linda Roback; Aarthi Sundararajan; Samuel H Speck; Edward S Mocarski; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2018-09-07       Impact factor: 5.422

4.  Caspase-8 restricts natural killer cell accumulation during MCMV Infection.

Authors:  Yanjun Feng; Lisa P Daley-Bauer; Linda Roback; Marc Potempa; Lewis L Lanier; Edward S Mocarski
Journal:  Med Microbiol Immunol       Date:  2019-05-21       Impact factor: 3.402

Review 5.  Manipulation of apoptosis and necroptosis signaling by herpesviruses.

Authors:  Hongyan Guo; William J Kaiser; Edward S Mocarski
Journal:  Med Microbiol Immunol       Date:  2015-04-01       Impact factor: 3.402

6.  Knocking 'em Dead: Pore-Forming Proteins in Immune Defense.

Authors:  Xing Liu; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2020-01-31       Impact factor: 28.527

Review 7.  RIP kinases: key decision makers in cell death and innate immunity.

Authors:  F Humphries; S Yang; B Wang; P N Moynagh
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

Review 8.  Resolution of inflammation: a new therapeutic frontier.

Authors:  James N Fullerton; Derek W Gilroy
Journal:  Nat Rev Drug Discov       Date:  2016-03-29       Impact factor: 84.694

9.  Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner.

Authors:  Stephanie A Conos; Kaiwen W Chen; Dominic De Nardo; Hideki Hara; Lachlan Whitehead; Gabriel Núñez; Seth L Masters; James M Murphy; Kate Schroder; David L Vaux; Kate E Lawlor; Lisa M Lindqvist; James E Vince
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

10.  RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.

Authors:  Shoko Nogusa; Roshan J Thapa; Christopher P Dillon; Swantje Liedmann; Thomas H Oguin; Justin P Ingram; Diego A Rodriguez; Rachelle Kosoff; Shalini Sharma; Oliver Sturm; Katherine Verbist; Peter J Gough; John Bertin; Boris M Hartmann; Stuart C Sealfon; William J Kaiser; Edward S Mocarski; Carolina B López; Paul G Thomas; Andrew Oberst; Douglas R Green; Siddharth Balachandran
Journal:  Cell Host Microbe       Date:  2016-06-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.